Skip to main content
SpringerLink
Log in

Preventative therapy plays an important role in managing chronic daily headache in paediatric patients

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

References

  1. Headache Classification Subcommittee of the International Headache Society. International classification of headache disorders. 2nd ed. Cephalalgia 2004; 24 Suppl. 1; 9–160

  2. Gladstein J, Holden EW, Peralta L, et al. Diagnoses and symptom patterns in children presenting to a pediatric headache clinic. Headache 1993; 33(9): 497–500

    Article  PubMed  CAS  Google Scholar 

  3. Hershey AD, Powers SW, Bentti AL, et al. Characterization of chronic daily headaches in children in a multidisciplinary headache center. Neurology 2001; 56(8): 1032–7

    Article  PubMed  CAS  Google Scholar 

  4. Mack KJ, Gladstein J. Management of chronic daily headache in children and adolescents. Pediatr Drugs 2008; 10(1): 23–9

    Article  Google Scholar 

  5. Mack KJ. An approach to children with chronic daily headache. Dev Med Child Neurol 2006; 48(12): 997–1000

    Article  PubMed  Google Scholar 

  6. Silberstein SD, Lipton RB, Solomon S, et al. Classification of daily and near-daily headaches: proposed revisions to the IHS criteria. Headache 1994; 34(1): 1–7

    Article  Google Scholar 

  7. Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 1996; 47(4): 871–5

    Article  PubMed  CAS  Google Scholar 

  8. Mack KJ. What incites new daily persistent headache in children? Pediatr Neurol 2004; 31(2): 122–5

    Article  PubMed  Google Scholar 

  9. Gladstein J, Holden EW. Chronic daily headache in children and adolescents: a 2-year prospective study. Headache 1996; 36(6): 349–51

    Article  PubMed  CAS  Google Scholar 

  10. Raskin NH. Repetitive intravenous ergotamine therapy for the treatment of intractable migraine. Neurology 1986; 36(7): 995–7

    Article  PubMed  CAS  Google Scholar 

  11. Mathew NT, Kailasam J, Meadors L, et al. Intravenous valproate sodium (depacon) aborts migraine rapidly: a preliminary report. Headache 2000; 40(9): 720–3

    Article  PubMed  CAS  Google Scholar 

  12. Krymchantowski AV, Barbosa JS. Dexamethasone decreases migraine recurrence observed after treatment with a triptan combined with a nonsteroidal anti-inflammatory drug. Arq Neuropsiquiatr 2001; 59(3B): 708–11

    Article  PubMed  CAS  Google Scholar 

  13. Pageler L, Savidou I, Limmroth V. Medication-overuse headache. Curr Pain Headache Rep 2005; 9(6): 430–5

    Article  PubMed  Google Scholar 

  14. Silberstein SD, Liu D. Drug overuse and rebound headache. Curr Pain Headache Rep 2002; 6(3): 240–7

    Article  PubMed  Google Scholar 

  15. Lewis D, Ashwal S, Hershey A, et al. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology 2004; 63(12): 2215–24

    Article  PubMed  CAS  Google Scholar 

  16. Fava M. Psychopharmacologic treatment of pathologic aggression. Psychiatr Clin North Am 1997; 20(2): 427–51

    Article  PubMed  CAS  Google Scholar 

  17. Gherpelli JL, Esposito SB. A prospective randomized double blind placebo controlled crossover study of fluoxetine efficacy in the prophylaxis of chronic daily headache in children and adolescents. Arq Neuropsiquiatr 2005; 63(3A): 559–63

    Article  PubMed  Google Scholar 

  18. Adelman LC, Adelman JU, Von Seggern R, et al. Venlafaxine extended release (XR) for the prophylaxis of migraine and tensiontype headache: a retrospective study in a clinical setting. Headache 2000; 40(7): 572–80

    Article  PubMed  CAS  Google Scholar 

  19. Bianchi A, Salomone S, Caraci F, et al. Role of magnesium, coenzyme Q10, riboflavin, and vitamin B12 in migraine prophylaxis. Vitam Horm 2004; 69: 297–312

    Article  PubMed  CAS  Google Scholar 

  20. Dodick DW, Mauskop A, Elkind AH, et al. Botulinum toxin type A for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo controlled study. Headache 2005; 45(4): 315–24

    Article  PubMed  Google Scholar 

  21. British Medical Association and the Royal Pharmaceutical Society of Great Britain. British national formulary. No. 56. London: BMJ Publishing Group Ltd and RPS Publishing, 2008 Sep

  22. Penzien DB, Rains JC, Andrasik F. Behavioral management of recurrent headache: three decades of experience and empiricism. Appl Psychophysiol Biofeedback 2002; 27(2): 163–81

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Preventative therapy plays an important role in managing chronic daily headache in paediatric patients. Drugs Ther. Perspect 25, 10–13 (2009). https://doi.org/10.2165/0042310-200925010-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/0042310-200925010-00003

Search

Navigation